• About
  • Contact
Thursday, July 3, 2025
No Result
View All Result
Londoner News
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
No Result
View All Result
Londoner News
No Result
View All Result
Home Markets

Daiichi case: Delhi HC allows sale of listed shares of Shivinder Singh

by The Editor
May 8, 2018
in Markets
0
Daiichi case: Delhi HC allows sale of listed shares of Shivinder Singh
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

New Delhi: The Delhi High Court has allowed the sale of unencumbered shares held by all respondents, except for Malvinder Singh, in listed companies towards the repayment of an arbitration award by Daiichi Sankyo.

The proceeds are to be deposited with the court registrar, Justice Jayant Nath said on Tuesday.

The chartered accountant is still in the process of valuation of these shares, according to the lawyer for the respondents.

The Delhi Debt Recovery Tribunal has ordered a stay on the sale of unencumbered assets of Malvinder Singh in a separate case by Yes Bank, the lawyers for the respondents told the court. The high court has issued a notice to Yes Bank seeking it's response.

The respondents on Tuesday moved an application seeking a stay on the enforcement proceedings as a Singapore court has reserved its judgment in an appeal by Malvinder and Shivinder Singh against Daiichi's award.

The counsel for the respondents told court that the judgment was expected in June and the proceedings to enforce the award here should be stayed until then.

The court will take up this application on May 14.

Daiichi Sankyo is seeking to recover over Rs3,500 crore from the Singhs, former promoters of Ranbaxy.

In 2016, a Singapore arbitration tribunal directed the brothers and other respondents like companies controlled by them to pay Daiichi damages for allegedly concealing information regarding wrongdoing at Ranbaxy when selling it to the Japanese drug maker for $4.6 billion in 2008.

Original Article

[contf] [contfnew]

ET Markets

[contfnewc] [contfnewc]

The Editor

Next Post
What you need to know before the open

What you need to know before the open

Recommended

It’s so cold in Canada penguins are staying inside to keep warm

It’s so cold in Canada penguins are staying inside to keep warm

8 years ago
Catalan leaders call for Madrid talks after violent clashes

Catalan leaders call for Madrid talks after violent clashes

6 years ago

Popular News

    Connect with us

    About Us

    We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

    Category

    • America
    • Britain
    • Entertainment
    • Europe
    • Health
    • International
    • latest news
    • London
    • Markets
    • Science
    • Tech
    • Travel
    • Uncategorized
    • Women

    Site Links

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • About
    • Contact

    © 2020 londonernews

    No Result
    View All Result
    • Home
    • Science
    • Travel
    • Tech
    • Health

    © 2020 londonernews